Lifetime Prevalence and Comorbidity of Mental Disorders in the Two-wave 2002-2018 Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (CAFVMHS): Prévalence et Comorbidité de Durée de vie Des Troubles Mentaux Dans l'Enquête de Suivi Sur la Santé Mentale Auprès des Membres des Forces Armées Canadiennes et Des ex-Militaires (ESSMFACM) en Deux Cycles de 2002 à 2018.
armed forces
common mental disorders
comorbidity
epidemiology
longitudinal study
military
prevalence
veteran
Journal
Canadian journal of psychiatry. Revue canadienne de psychiatrie
ISSN: 1497-0015
Titre abrégé: Can J Psychiatry
Pays: United States
ID NLM: 7904187
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
pubmed:
16
3
2021
medline:
15
12
2021
entrez:
15
3
2021
Statut:
ppublish
Résumé
The current study used the Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (CAFVMHS) to (1) examine the incidence and prevalence of mental disorders and (2) estimate the comorbidity of mental disorders over the follow-up period. The CAFVMHS (2018) is a longitudinal study with two time points of assessment. The sample is comprised of 2,941 Canadian Forces members and veterans who participated in the 2002 Canadian Community Health Survey: Canadian Forces Supplement. The World Health Organization Composite International Diagnostic Interview (WHO-CIDI) was utilized to diagnose In 2018, lifetime prevalence of any WHO-CIDI-based or self-reported mental disorder was 58.1%. Lifetime prevalence of any mood or anxiety disorder or PTSD was 54.0% in 2018. MDE (39.9%), SAD (25.7%), and PTSD (21.4%) were the most common mental disorders. There was a substantial increase in new onset or recurrence/persistence of mental disorders between the two measurement points (16-year assessment gap); 2002-2018 period prevalences were 43.5% for mood and anxiety disorder and 16.8% for alcohol abuse or dependence. The prevalence of self-reported ADHD, OCD, any personality disorder, and mania were 3.3%, 3.0%, 0.8%, and 0.8%, respectively. Comorbidity between mental disorders increased over the follow-up. This study demonstrates a high burden of mental disorders among a large Canadian military and veteran cohort. These findings underscore the importance of prevention and intervention strategies to reduce the burden of mental disorders and alcohol use disorders in these populations.
Identifiants
pubmed: 33715467
doi: 10.1177/07067437211000636
pmc: PMC8649821
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
951-960Subventions
Organisme : CIHR
ID : 333252
Pays : Canada
Références
Arch Intern Med. 2009 Dec 14;169(22):2142-7
pubmed: 20008700
CMAJ. 2014 Jun 10;186(9):E324-32
pubmed: 24756625
Clin Psychol Psychother. 2018 Mar 25;:
pubmed: 29575290
BMC Psychiatry. 2009 May 08;9:19
pubmed: 19422724
J Trauma Stress. 1996 Apr;9(2):235-52
pubmed: 8731545
Am J Geriatr Psychiatry. 2014 Sep;22(9):854-65
pubmed: 23800537
Am J Epidemiol. 2008 Jun 1;167(11):1269-76
pubmed: 18436536
J Psychiatr Res. 2010 Oct;44(14):887-93
pubmed: 20378128
Int J Methods Psychiatr Res. 2009 Dec;18(4):221-8
pubmed: 20052690
N Engl J Med. 2004 Jul 1;351(1):13-22
pubmed: 15229303
Br J Psychiatry. 2018 Dec;213(6):690-697
pubmed: 30295216
PLoS Med. 2009 Mar 3;6(3):e35
pubmed: 19260759
Can J Psychiatry. 2021 Nov;66(11):971-981
pubmed: 33406886
Psychol Med. 2010 Jun;40(6):899-909
pubmed: 19719899
Can J Public Health. 2014 Apr 09;105(2):e109-15
pubmed: 24886845
J Psychiatr Res. 1994 Jan-Feb;28(1):57-84
pubmed: 8064641
Can J Psychiatry. 2021 Nov;66(11):942-950
pubmed: 33624524
Lancet. 2010 May 22;375(9728):1783-97
pubmed: 20471076
Int J Geriatr Psychiatry. 2015 Jul;30(7):677-85
pubmed: 25345806
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
CMAJ. 2013 Aug 6;185(11):E545-52
pubmed: 23820441
Can J Psychiatry. 2021 Nov;66(11):982-995
pubmed: 33522288
Psychol Med. 2013 Jan;43(1):73-84
pubmed: 22608015
Soc Psychiatry Psychiatr Epidemiol. 2012 May;47(5):691-6
pubmed: 21533819
Am J Public Health. 2008 Dec;98(12):2191-8
pubmed: 18923111
Biol Psychiatry. 2005 Jun 1;57(11):1442-51
pubmed: 15950019
J Clin Epidemiol. 2007 Feb;60(2):192-201
pubmed: 17208126
Can J Psychiatry. 2016 Apr;61(1 Suppl):26S-35S
pubmed: 27270739
Am J Epidemiol. 1998 Aug 15;148(4):315-23
pubmed: 9717872
Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
pubmed: 27866355
Arch Gen Psychiatry. 2003 Nov;60(11):1117-22
pubmed: 14609887
J Behav Health Serv Res. 2019 Jul;46(3):384-398
pubmed: 30218429
PLoS Med. 2009 Mar 3;6(3):e26
pubmed: 19260757
Can J Psychiatry. 2021 Nov;66(11):996-998
pubmed: 33739174
Can J Psychiatry. 2016 Apr;61(1 Suppl):10S-25S
pubmed: 27270738
J Pers Disord. 2010 Aug;24(4):412-26
pubmed: 20695803
Can J Psychiatry. 2010 Jul;55(7):464-72
pubmed: 20704774
Am J Public Health. 2015 Dec;105(12):2564-9
pubmed: 26474009
Biol Psychiatry. 2007 Sep 15;62(6):553-64
pubmed: 17217923
J Anxiety Disord. 2003;17(5):573-82
pubmed: 12941367
Am J Psychiatry. 2015 Nov 1;172(11):1101-11
pubmed: 26337036
CMAJ. 2016 Aug 9;188(11):E261-E267
pubmed: 27221270
Arch Gen Psychiatry. 1988 Dec;45(12):1069-77
pubmed: 2848472
Can J Public Health. 2013 Jan 07;104(1):e15-21
pubmed: 23618114
J Affect Disord. 2016 Sep 15;202:171-7
pubmed: 27262639
Mol Psychiatry. 2010 Jan;15(1):53-63
pubmed: 18725912
Arch Gen Psychiatry. 2007 Jul;64(7):843-52
pubmed: 17606818
J Affect Disord. 2013 May 15;148(1):77-83
pubmed: 23246365
Can J Psychiatry. 2016 Apr;61(1 Suppl):46S-55S
pubmed: 27270741